Late complications of immune deviation therapy in a nonhuman primate

被引:293
作者
Genain, CP
Abel, K
Belmar, N
Villinger, F
Rosenberg, DP
Linington, C
Raine, CS
Hauser, SL
机构
[1] EMORY UNIV,SCH MED,DEPT PATHOL & LAB MED,ATLANTA,GA 30322
[2] MAX PLANCK INST PSYCHIAT,DEPT NEUROIMMUNOL,D-8033 MARTINSRIED,GERMANY
[3] ALBERT EINSTEIN COLL MED,DEPT PATHOL,BRONX,NY 10461
关键词
D O I
10.1126/science.274.5295.2054
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The administration of antigens in soluble form can induce antigen-specific immune tolerance and suppress experimental autoimmune diseases, In a marmoset model of multiple sclerosis induced by myelin oligodendrocyte glycoprotein (MOG), marmosets tolerized to MOG were protected against acute disease, but after tolerization treatment a lethal demyelinating disorder emerged. In these animals, MOG-specific T cell proliferative responses were transiently suppressed, cytokine production was shifted from a T helper type 1 (T(H)1) to a T(H)2 pattern, and titers of autoantibodies to MOG were enhanced. Thus, immune deviation can increase concentrations of pathogenic autoantibodies and in some circumstances exacerbate autoimmune disease.
引用
收藏
页码:2054 / 2057
页数:4
相关论文
共 43 条
[1]  
AMOR S, 1994, J IMMUNOL, V153, P4349
[2]  
[Anonymous], 1983, MULTIPLE SCLEROSIS P
[3]   SURFACE EXPRESSION OF ALPHA-4 INTEGRIN BY CD4 T-CELLS IS REQUIRED FOR THEIR ENTRY INTO BRAIN PARENCHYMA [J].
BARON, JL ;
MADRI, JA ;
RUDDLE, NH ;
HASHIM, G ;
JANEWAY, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) :57-68
[4]   Mechanisms of immune injury in multiple sclerosis [J].
Brosnan, CF ;
Raine, CS .
BRAIN PATHOLOGY, 1996, 6 (03) :243-257
[5]   REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE - SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CHEN, YH ;
KUCHROO, VK ;
INOBE, J ;
HAFLER, DA ;
WEINER, HL .
SCIENCE, 1994, 265 (5176) :1237-1240
[6]   IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE-SCLEROSIS [J].
COMPSTON, DAS ;
MORGAN, BP ;
CAMPBELL, AK ;
WILKINS, P ;
COLE, G ;
THOMAS, ND ;
JASANI, B .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1989, 15 (04) :307-316
[7]   T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CRITCHFIELD, JM ;
RACKE, MK ;
ZUNIGAPFLUCKER, JC ;
CANNELLA, B ;
RAINE, CS ;
GOVERMAN, J ;
LENARDO, MJ .
SCIENCE, 1994, 263 (5150) :1139-1143
[8]   LONG-TERM INHIBITION OF MURINE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS USING CTLA-4-FC SUPPORTS A KEY ROLE FOR CD28 COSTIMULATION [J].
CROSS, AH ;
GIRARD, TJ ;
GIACOLETTO, KS ;
EVANS, RJ ;
KEELING, RM ;
LIN, RF ;
TROTTER, JL ;
KARR, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2783-2789
[9]   VESICULAR DISRUPTION OF MYELIN IN AUTOIMMUNE DEMYELINATION [J].
DALCANTO, MC ;
WISNIEWSKI, HM ;
JOHNSON, AB ;
BROSTOFF, SW ;
RAINE, CS .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1975, 24 (03) :313-319
[10]   REACTIVITY TO MYELIN ANTIGENS IN MULTIPLE-SCLEROSIS - PERIPHERAL-BLOOD LYMPHOCYTES RESPOND PREDOMINANTLY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN [J].
DEROSBO, NK ;
MILO, R ;
LEES, MB ;
BURGER, D ;
BERNARD, CCA ;
BENNUN, A .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2602-2608